Efficacy and Comparative Effectiveness of Atypical Antipsychotic Medications for Off-Label Uses in Adults: A Systematic Review and Meta-analysis

Maher, Alicia Ruelaz, Maglione, Margaret, Bagley, Steven, Suttorp, Marika, Hu, Jian-Hui, Ewing, Brett, Wang, Zhen, Timmer, Martha, Sultzer, David, Shekelle, Paul G.·2011·JAMA

DOI 10.1001/jama.2011.1360

Cited by (559)

Items 101–200 of 559

Antipsychotics result in more weight gain in antipsychotic naive patients than in patients after antipsychotic switch and weight gain is irrespective of psychiatric diagnosis: A meta-analysis
Maarten Bak, Marjan Drukker, Shauna A M Cortenraad, Emma Vandenberk, Sinan Gülöksüz · 2021 · PLoS ONE
A systematic review and combined analysis of therapeutic drug monitoring studies for long-acting paliperidone
Schoretsanitis, Georgios, Spina, Edoardo, Hiemke, Christoph, de Leon, Jose · 2018 · Expert Review of Clinical Pharmacology
Antipsychotic agents in the treatment of anorexia nervosa: neuropsychopharmacologic rationale and evidence from controlled trials
Brewerton, Timothy D. · 2012 · Current Psychiatry Reports
Potentially inappropriate medications in the elderly: a comprehensive protocol
Suzana Mimica Matanović, Vera Vlahović–Palčevski · 2012 · European Journal of Clinical Pharmacology
Progresses in treating agitation: a major clinical challenge in Alzheimer’s disease
Francesco Panza, Vincenzo Solfrizzi, Davide Seripa, Bruno Pietro Imbimbo, Andrea Santamato, Madia Lozupone, Camilla Prete, Antonio Greco, Alberto Pilotto, Giancarlo Logroscino · 2015 · Expert Opinion on Pharmacotherapy
Empfehlungen zur Diagnostik und Therapie der behavioralen und psychologischen Symptome der Demenz (BPSD)
Egemen Savaskan, Irene Bopp-Kistler, Markus Bürge, Regina Fischlin, Dan Georgescu, Umberto Giardini, Martin Hatzinger, Ulrich Hemmeter, Isabella Justiniano, Reto Werner Kressig et al. · 2014 · Praxis
Rationales that Providers and Family Members Cited for the Use of Antipsychotic Medications in Nursing Home Residents with Dementia
Alice Bonner, Terry S. Field, Celeste A. Lemay, Kathleen M. Mazor, Daniel A. Andersen, Christina Compher, Jennifer Tjia, Jerry H. Gurwitz · 2015 · Journal of the American Geriatrics Society
Effect of an interactive therapeutic robotic animal on engagement, mood states, agitation and psychotropic drug use in people with dementia: a cluster-randomised controlled trial protocol
Wendy Moyle, Elizabeth Beattie, Brian Draper, David Shum, Lukman Thalib, Cindy Jones, Siobhan O’Dwyer, Cindy Mervin · 2015 · BMJ Open
Knowledge of and Perceived Need for Evidence-Based Education About Antipsychotic Medications Among Nursing Home Leadership and Staff
Celeste A. Lemay, Kathleen M. Mazor, Terry S. Field, Jennifer L. Donovan, Abir O. Kanaan, Becky A. Briesacher, Sarah Foy, Leslie R. Harrold, Jerry H. Gurwitz, Jennifer Tjia · 2013 · Journal of the American Medical Directors Association
Genome-wide meta-analysis, functional genomics and integrative analyses implicate new risk genes and therapeutic targets for anxiety disorders
Wenqiang Li, Rui Chen, Laipeng Feng, Xinglun Dang, Jiewei Liu, Tengfei Chen, Jinfeng Yang, Xi Su, Luxian Lv, Tao Li et al. · 2023 · Nature Human Behaviour
Increasing use of atypical antipsychotics and anticonvulsants during pregnancy
Richard Allen EPSTEIN, William Victor Bobo, Richard Charles Shelton, Patrick G. Arbogast, James Morrow, Wei Wang, Rameela Chandrasekhar, William O. Cooper · 2012 · Pharmacoepidemiology and Drug Safety
A pharmacy led program to review anti-psychotic prescribing for people with dementia
Anne Child, Amy Clarke, Chris Fox, Ian Maidment · 2012 · BMC Psychiatry
‘Use of antipsychotics in children and adolescents: a picture from the ARITMO population-based European cohort study’
Florentia Kaguelidou, Jakob Holstiege, Tania Schink, Irene D. Bezemer, Elisabetta Poluzzi, Giampiero Mazzaglia, Lars Henning Pedersen, Miriam Sturkenboom, Gianluca Trifirò · 2020 · Epidemiology and Psychiatric Sciences
New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer’s disease: focus on brexpiprazole and pimavanserin
Filippo Caraci, Mario Santagati, Giuseppe Caruso, Dario Cannavò, Gian Marco Leggio, Salvatore Salomone, Filippo Drago · 2020 · F1000Research
Sedation mediates part of Citalopram's effect on agitation in Alzheimer's disease
Jeffery A. Newell, Jerome Albert Yesavage, Joy L. Taylor, HELENA CHMURA KRAEMER, Cynthia A. Munro, Leah Friedman, Paul B. Rosenberg, Michelle R. Madore, Steven Z. Chao, Davangere P. Devanand et al. · 2015 · Journal of Psychiatric Research
Therapeutic dilemma’s: antipsychotics use for neuropsychiatric symptoms of dementia, delirium and insomnia and risk of falling in older adults, a clinical review
Netta Korkatti-Puoskari, Miia Tiihonen, María Ángeles Caballero Mora, Eva Topinková, Katarzyna E. Szczerbińska, Sirpa A. Hartikainen, on the Behalf of the EuGMS Task & Finish group on FRIDs · 2023 · European Geriatric Medicine
Impact of individualised music listening intervention on persons with dementia: A systematic review of randomised controlled trials
Minah Amor Gaviola, Kerry Inder, Sophie Dilworth, Elizabeth G. Holliday, Isabel Johanna Higgins · 2019 · Australian Journal on Ageing
Depressive symptoms in long term care facilities in Western Canada: a cross sectional study
Matthias Hoben, Abigail Heninger, Jayna Marie Holroyd-Leduc, Jennifer Knopp‐Sihota, Carole A. Estabrooks, Zahra Goodarzi · 2019 · BMC Geriatrics
A systematic review and combined analysis of therapeutic drug monitoring studies for oral paliperidone
Georgios Schoretsanitis, Edoardo Spina, Christoph Hiemke, José de León · 2018 · Expert Review of Clinical Pharmacology
Antipsychotic Drug Use and the Risk of Venous Thromboembolism in Elderly Patients With Dementia
Niklas Schmedt, Edeltraut Garbe · 2013 · Journal of Clinical Psychopharmacology
Motor and non-motor features of Parkinson's disease that predict persistent drug-induced Parkinsonism
James F. Morley, Stephanie M. Pawlowski, Adhithi Kesari, Ivy W. Maina, Alexander Y. Pantelyat, John E. Duda · 2014 · Parkinsonism & Related Disorders
Pharmacogenetics of Clinical Response to Risperione
Adrián LLerena, Roland Berecz, Eva Peñas‐Lledó, Ágnes Süveges, Humberto Fariñas · 2013 · Pharmacogenomics
Medication development for agitation and aggression in Alzheimer disease: review and discussion of recent randomized clinical trial design
Maria Eugenia Soto, Sandrine Andrieu, Fati Nourhashémi, Pierre‐Jean Ousset, Clive G. Ballard, Philippe Henri Robert, Bruno J. Vellas, Constantine George Lyketsos, Paul B. Rosenberg · 2014 · International Psychogeriatrics
Effects of antipsychotic drugs on neurites relevant to schizophrenia treatment
Xu‐Feng Huang, Xueqin Song · 2018 · Medicinal Research Reviews
RETRACTED ARTICLE: Efficacy and safety of atypical antipsychotic drug treatment for dementia: a systematic review and meta-analysis
Lin Tan, Lan Tan, Hui-Fu Wang, Jun Wang, Chen‐Chen Tan, Meng‐Shan Tan, Xiangfei Meng, Chong Wang, Jin‐Tai Yu · 2015 · Alzheimer s Research & Therapy · Retracted
Psychotropic medication use in youth at high risk for psychosis: Comparison of baseline data from two research cohorts 1998–2005 and 2008–2011
Scott W. Woods, Jean Addington, Carrie E. Bearden, Kristin S. Cadenhead, Tyrone D. Cannon, Barbara A. Cornblatt, Daniel H. Mathalon, Diana O. Perkins, Larry J. Seidman, Ming T. Tsuang et al. · 2013 · Schizophrenia Research
New approaches to the pharmacological management of generalized anxiety disorder
Massimiliano Buoli, Alice Caldiroli, Elisabetta Caletti, Riccardo Augusto Paoli, Alfredo Carlo Altamura · 2013 · Expert Opinion on Pharmacotherapy
Neuroadaptations to antipsychotic drugs: Insights from pre-clinical and human post-mortem studies
Davide Amato, Clare L. Beasley, Margaret Hahn, Anthony Christopher Vernon · 2016 · Neuroscience & Biobehavioral Reviews
Prevalence of, and Resident and Facility Characteristics Associated With Antipsychotic Use in Assisted Living vs. Long-Term Care Facilities: A Cross-Sectional Analysis from Alberta, Canada
Kathryn J. Stock, Joseph Emmanuel Amuah, Kate L. Lapane, David B. Hogan, Colleen Jean Maxwell · 2016 · Drugs & Aging
Pimavanserin in Alzheimer's Disease Psychosis: Efficacy in Patients with More Pronounced Psychotic Symptoms
Ballard, Clive, Youakim, J.M., Coate, B., Stankovic, S. · 2019 · The Journal of Prevention of Alzheimer's Disease
Trends in Antipsychotic and Mood Stabilizer Prescribing in Long-Term Care in the U.S.: 2011–2014
Lauren B. Gerlach, Helen C. Kales, Hyungjin Myra Kim, Julie Bynum, Claire Chiang, Julie Strominger, Donovan T. Maust · 2020 · Journal of the American Medical Directors Association
Comparative Outcomes of Commonly Used Off-Label Atypical Antipsychotics in the Treatment of Dementia-Related Psychosis: A Network Meta-analysis
Ismaeel U. Yunusa, Nazia Rashid, George Demos, B Mahadik, Victor Abler, Krithika Rajagopalan · 2022 · Advances in Therapy
Advancements in the treatment of agitation in Alzheimer’s disease
Inga Margret Antonsdottir, Jessica Simons Smith, Melanie Keltz, Anton P. Porsteinsson · 2015 · Expert Opinion on Pharmacotherapy
Are the Safety Profiles of Antipsychotic Drugs Used in Dementia the Same? An Updated Review of Observational Studies
Gianluca Trifirò, Janet Sultana, Edoardo Spina · 2014 · Drug Safety
Associated Factors With Antipsychotic Use in Long-Term Institutional Care in Eight European Countries: Results From the RightTimePlaceCare Study
Adélaïde De Mauléon, Sandrine Sourdet, Anna Renom Guiteras, Sophie Guyonnet, Helena Leino‐Kilpi, Staffan Karlsson, Michel H.C. Bleijlevens, Adelaida Zabalegui, Kai Saks, Bruno J. Vellas et al. · 2014 · Journal of the American Medical Directors Association
Asenapine for elderly bipolar manic patients
Yehuda Baruch, Shelly Tadger, Igor Plopski, Yoram Barak · 2012 · Journal of Affective Disorders
Comprehensive review of generalized anxiety disorder in primary care in Europe.
Parmentier, H., García-Campayo, J., Prieto, R. · 2013 · Current Medical Research and Opinion
Approach to Management of Wandering in Dementia: Ethical and Legal Issue
Adesh Kumar Agrawal, Mahesh Gowda, Umesh Achary, Guru S. Gowda, Vijaykumar Harbishettar · 2021 · Indian Journal of Psychological Medicine
The neurobiology of aggression: implications for the pharmacotherapy of aggressive challenging behaviour by people with intellectual disabilities
Paul Willner · 2014 · Journal of Intellectual Disability Research
The use of non-pharmacological interventions for dementia behaviours in care homes: findings from four in-depth, ethnographic case studies
Tamara Backhouse, Anne Killett, Bridget Penhale, Richard John Gray · 2016 · Age and Ageing
Association between antipsychotic treatment and leptin levels across multiple psychiatric populations: An updated meta‐analysis
Renee‐Marie Ragguett, Margaret Hahn, Giovanni Messina, Sergio Chieffi, Marcellino Monda, Vincenzo De Luca · 2017 · Human Psychopharmacology Clinical and Experimental
Critical Review of the Use of Second-Generation Antipsychotics in Obsessive–Compulsive and Related Disorders
Dongmi Kim, Nicole Ryba, Julie Kalabalik, Ligia Westrich · 2018 · Drugs in R&D
Off-Label Prescribing in Older Patients
Stephen H. Jackson, Paul A. F. Jansen, Arduino Aleksander Mangoni · 2012 · Drugs & Aging
Antipsychotics and Associated Risk of Out-of-Hospital Cardiac Arrest
Peter Ejvin Weeke, Aksel Karl Georg Jensen, Fredrik Folke, Gunnar Gislason, Jonas Bjerring Olesen, Emil Loldrup Fosbøl, Mads Wissenberg, Freddy Knudsen Lippert, Erika Frischknecht Christensen, Søren Loumann Nielsen et al. · 2014 · Clinical Pharmacology & Therapeutics
Potentially inappropriate prescribing detected by STOPP–START criteria: are they really inappropriate?
Isabel Lozano-Montoya, Manuel Vélez‐Díaz‐Pallarés, Eva Delgado‐Silveira, Beatriz Montero‐Errasquín, Alfonso José Cruz-Jentoft · 2015 · Age and Ageing
Association of a Communication Training Program With Use of Antipsychotics in Nursing Homes
Jennifer Tjia, Jacob N. Hunnicutt, Laurie Herndon, Carolyn Blanks, Kate L. Lapane, Susan Wehry · 2017 · JAMA Internal Medicine
Second-generation antipsychotic use during pregnancy and risk of congenital malformations
Maria A. Ellfolk, Maarit K. Leinonen, Mika Gissler, Sonja Kiuru‐Kuhlefelt, Leena Saastamoinen, Heli T. Malm · 2021 · European Journal of Clinical Pharmacology
Role of quetiapine beyond its clinical efficacy in bipolar disorder: From neuroprotection to the treatment of psychiatric disorders (Review)
Márcio Gerhardt Soeiro‐de‐Souza, Vasco Videira Dias, Giovani Missio, Vicent Balanzá‐Martínez, Leandro Da Costa Lane Valiengo, Andre Ferrer Carvalho, Ricardo Alberto Moreno · 2015 · Experimental and Therapeutic Medicine
Behavioral or neuropsychiatric symptoms of Alzheimer’s disease: from psychopathology to pharmacological management.
Teixeira, Antonio Lucio, Rocha, Natalia Pessoa, Gatchel, Jennifer · 2023 · Arquivos de Neuro-Psiquiatria
Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer’s Disease
Marjaana Koponen, Heidi T. Taipale, Piia Lavikainen, Antti J. Tanskanen, Jari Tiihonen, Anna‐Maija Tolppanen, Riitta S. Ahonen, Sirpa A. Hartikainen · 2016 · Journal of Alzheimer s Disease
Dissemination of Evidence‐Based Antipsychotic Prescribing Guidelines to Nursing Homes: A Cluster Randomized Trial
Jennifer Tjia, Terry S. Field, Kathleen M. Mazor, Celeste A. Lemay, Abir O. Kanaan, Jennifer L. Donovan, Becky A. Briesacher, Daniel Peterson, Michelle M. Pandolfi, Ann Spenard et al. · 2015 · Journal of the American Geriatrics Society
Haloperidol inactivates AMPK and reduces tau phosphorylation in a tau mouse model of Alzheimer's disease
Jeremy L. Koppel, Heidy T. Jimenez, Leslie R. Adrien, BLAINE S. GREENWALD, Philippe Marambaud, Ezra Cinamon, Peter Davies · 2016 · Alzheimer s & Dementia Translational Research & Clinical Interventions
Trichotillomania is more related to Tourette disorder than to obsessive-compulsive disorder
Hugues Lamothe, Jean‐Marc Baleyte, Luc Mallet, Antoine Pélissolo · 2019 · Brazilian Journal of Psychiatry
Effects of antipsychotic treatment on cognition in healthy subjects
Tanja Veselinović, Holger Schorn, Ingo Vernaleken, Christoph Hiemke, Gerald Zernig, Ruben C. Gur, Gerhard Gründer · 2012 · Journal of Psychopharmacology
A Pilot Study Using Machine Learning and Domain Knowledge to Facilitate Comparative Effectiveness Review Updating
Siddhartha R. Dalal, Paul Shekelle, Susanne Hempel, Sydne Jennifer Newberry, Aneesa Motala, Kanaka D Shetty · 2012 · Medical Decision Making
Effect of person-centred care on antipsychotic drug use in nursing homes (EPCentCare): study protocol for a cluster-randomised controlled trial
Christin Richter, Almuth Berg, Steffen Fleischer, Sascha Köpke, Katrin Balzer, Eva-Maria Fick, Andreas C. Sönnichsen, Susanne Löscher, Horst Christian Vollmar, Burkhard Haastert et al. · 2015 · Implementation Science
Detecting and Managing Adverse Effects of Antipsychotic Medications
Donna Ames, Sian M. Carr‐Lopez, Mary A. Gutierrez, Joseph M. Pierre, Jennifer A. Rosen, Susan Shakib, Lynn M. Yudofsky · 2016 · Psychiatric Clinics of North America
Atypical Antipsychotic Medications and Hyponatremia in Older Adults: A Population-Based Cohort Study
Sonja Gandhi, Eric McArthur, Jeffrey P. Reiss, Muhammad Mamdani, Daniel G. Hackam, Matthew A. Weir, Amit X. Garg · 2016 · Canadian Journal of Kidney Health and Disease
A Guide to the Extrapyramidal Side-Effects of Antipsychotic Drugs
David G. Cunningham Owens · 2014 · Cambridge University Press eBooks
Drug prescriptions in nursing home residents: an Italian multicenter observational study
Luca Pasina, Alessio Novella, Laura Cortesi, Alessandro Nobili, Mauro Tettamanti, Aladar Ianes · 2020 · European Journal of Clinical Pharmacology
Comparative Analysis of the Pre- and Post-Medication Effects of Antipsychotic Agents on the Blood-Based Oxidative Stress Biomarkers in Patients with Schizophrenia: A Meta-Analysis
Mi Yang, Chunzhi Wang, Guocheng Zhao, Di Kong, Liju Liu, Shuai Yuan, Wei Chen, Can Feng, Zezhi Li · 2022 · Current Neuropharmacology
Attenuated psychotic and basic symptom characteristics in adolescents with ultra-high risk criteria for psychosis, other non-psychotic psychiatric disorders and early-onset psychosis
Nella Lo Cascio, Riccardo Saba, Marta Hauser, Ditte Lammers Vernal, Aseel Al‐Jadiri, Yehonatan Borenstein, Eva M. Sheridan, Taishiro Kishimoto, Marco Armando, Stefano Vicari et al. · 2016 · European Child & Adolescent Psychiatry
Increased Reporting of Exclusionary Diagnoses Inflate Apparent Reductions in Long-Stay Antipsychotic Prescribing
Jonathan D. Winter, John William Kerns, Katherine M. Winter, Roy Sabo · 2017 · Clinical Gerontologist
Tardive dyskinesia among patients using antipsychotic medications in customary clinical care in the United States
Anita M. Loughlin, Nancy D. Lin, Victor Abler, Benjamin Carroll · 2019 · PLoS ONE
Indications of atypical antipsychotics in the elderly
Andrew McKean, Erik Monasterio · 2014 · Expert Review of Clinical Pharmacology
Acute anxiolytic effects of quetiapine during virtual reality exposure—A double-blind placebo-controlled trial in patients with specific phobia
Julia Diemer, Katharina Domschke, Andreas Mühlberger, Bernward Winter, Maxim Zavorotnyy, Swantje Notzon, Karen Silling, Volker Arolt, Peter Zwanzger · 2013 · European Neuropsychopharmacology
Exercise Protects Against Olanzapine-Induced Hyperglycemia in Male C57BL/6J Mice
Laura N. Castellani, Willem T. Peppler, Paula Michelle Miotto, Natasha D. Bush, David Charles Wright · 2018 · Scientific Reports
Pharmacotherapy of schizophrenia: Mechanisms of antipsychotic accumulation, therapeutic action and failure
Daria Chestnykh, Davide Amato, Johannes Kornhuber, Christian P. Müller · 2021 · Behavioural Brain Research
Effect of Quetiapine, from Low to High Dose, on Weight and Metabolic Traits: Results from a Prospective Cohort Study
Céline Dubath, Marianna Piras, Mehdi Gholam, Nermine Laaboub, Claire Grosu, Othman Sentissi, Franziska Gamma, Alessandra Solida, Armin von Gunten, Philippe Conus et al. · 2021 · Pharmacopsychiatry
AMPK β1 activation suppresses antipsychotic‐induced hyperglycemia in mice
Hesham Shamshoum, Kyle D. Medak, Logan K. Townsend, Kristen E. Ashworth, Natasha D. Bush, Margaret K. Halm, Bruce E. Kemp, David Charles Wright · 2019 · The FASEB Journal
Investigational drugs for treating agitation in persons with dementia
Ricardo Pablo Garay, Leslie Citrome, George Thomas Grossberg, Icilio Cavero, Pierre‐Michel Llorca · 2016 · Expert Opinion on Investigational Drugs
Attempting to discontinue antipsychotic medication: Withdrawal methods, relapse and success
Miriam Larsen-Barr, Fred W. Seymour, John Read, Kerry L Gibson · 2018 · Psychiatry Research
Association between the glyco-metabolic adverse effects of antipsychotic drugs and their chemical and pharmacological profile: a network meta-analysis and regression
Carla Carnovale, Ersilia Lucenteforte, Vera Battini, Faizan Mazhar, Marco Fornili, Elena Invernizzi, Giulia Mosini, Michele Gringeri, Annalisa Capuano, Cristina Scavone et al. · 2021 · Psychological Medicine
An umbrella review on the use of antipsychotics in anxiety disorders: A registered report protocol
Amir Garakani, Rafael C. R. Freire, Frank Daniel Buono, Robyn Pauline Thom, Kaitlyn Larkin, Melissa Christine Funaro, Mona Salehi, M. Mercedes Pérez-Rodríguez · 2022 · PLoS ONE
Neurodegenerative Diseases: New Hopes and Perspectives
Mohammad Aadil Bhat, Suneela Sunil Dhaneshwar · 2023 · Current Molecular Medicine
Comparative risk of death in older adults treated with antipsychotics: A population-based cohort study
Niklas Schmedt, Bianca Kollhorst, Dirk Enders, Kathrin Jobski, Jutta Krappweis, Edeltraut Garbe, Tania Schink · 2016 · European Neuropsychopharmacology
Peripheral mechanisms of acute olanzapine induced metabolic dysfunction: A review of in vivo models and treatment approaches
Hesham Shamshoum, Kyle D. Medak, David Charles Wright · 2020 · Behavioural Brain Research
Risk Management for the 21st Century: Current Status and Future Needs
Rania Mouchantaf, Doris Auth, Yola Moride, June M. Raine, Soon Young Han, Meredith Y. Smith · 2021 · Drug Safety
Antipsychotic Drugs and Risk of Hip Fracture in People Aged 60 and Older in Norway
Marit Stordal Bakken, Jan Didrik Schjøtt, Anders Engeland, Lars Birger Engesaeter, Sabine Ruths · 2016 · Journal of the American Geriatrics Society
AICAR Prevents Acute Olanzapine-Induced Disturbances in Glucose Homeostasis
Natasha D. Bush, Logan K. Townsend, David Charles Wright · 2018 · Journal of Pharmacology and Experimental Therapeutics
Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
Amir Garakani, James W. Murrough, Rafael C. R. Freire, Robyn Pauline Thom, Kaitlyn Larkin, Frank Daniel Buono, Dan Vlad Iosifescu · 2021 · FOCUS The Journal of Lifelong Learning in Psychiatry
The doll therapy as a first line treatment for behavioral and psychologic symptoms of dementia in nursing homes residents: a randomized, controlled study
Francesca Santagata, Massimiliano Massaia, Patrizia D’Amelio · 2021 · BMC Geriatrics
Comparative study of two antipsychotic drugs binding to human serum albumin: By multispectroscopic and molecular docking methods
Ze-Yue Huang, Xiaoyun Li, Lan-Yi Hu, Ai‐Min Bai, Yan‐Jun Hu · 2022 · Journal of Molecular Liquids
Impact of TimeSlips Creative Expression Program on Behavioral Symptoms and Psychotropic Medication Use in Persons with Dementia in Long-term Care: A Cluster-randomized Pilot Study
Winona S. Houser, Daniel R. George, Vernon M. Chinchilli · 2013 · American Journal of Geriatric Psychiatry
Incidence of antipsychotic use in relation to diagnosis of Alzheimer's disease among community-dwelling persons
Marjaana Koponen, Anna‐Maija Tolppanen, Heidi T. Taipale, Antti J. Tanskanen, Jari Tiihonen, Kristina Johnell, Johan Fastbom, Riitta S. Ahonen, Sirpa A. Hartikainen · 2015 · The British Journal of Psychiatry
Trends in antipsychotic prescriptions for Japanese outpatients during 2006-2012: a descriptive epidemiological study
Kenji Kochi, Izumi Sato, Chika Nishiyama, Sachiko Tanaka‐Mizuno, Yuko Doi, Masaru Arai, Yosuke Fujii, Toshiyuki Matsunaga, Yusuke Ogawa, Toshi A. Furukawa et al. · 2017 · Pharmacoepidemiology and Drug Safety
Visual hallucinations in Alzheimer's disease do not seem to be associated with chronic hypoperfusion of to visual processing areas V2 and V3 but may be associated with reduced cholinergic input to these areas
Lindsey Isla Sinclair, Amit Kumar, Taher Darreh‐Shori, Seth Love · 2019 · Alzheimer s Research & Therapy
Psychotropic Medication and Cognitive, Functional, and Neuropsychiatric Outcomes in Alzheimer's Disease (AD)
Esther S. Oh, Paul B. Rosenberg, Gail B. Rattinger, Elizabeth A. Stuart, Constantine George Lyketsos, Jeannie‐Marie Leoutsakos · 2020 · Journal of the American Geriatrics Society
Sports and Functional Training Improve a Subset of Obesity-Related Health Parameters in Adolescents: A Randomized Controlled Trial
Bráulio Henrique Magnani Branco, Isabela Ramos Mariano, Leonardo Pestillo de Oliveira, Sônia Maria Marques Gomes Bertolini, Fabiano Mendes de Oliveira, Cynthia Gobbi, Kristi B. Adamo · 2021 · Frontiers in Psychology
Off-label use of antipsychotic medications in psychiatric inpatients in China: a national real-world survey
Juan Wang, Feng Jiang, Yating Yang, Yulong Zhang, Zhiwei Liu, Xiaorong Qin, Xueqin Tao, Tingfang Liu, Yuanli Liu, Yi‐lang Tang et al. · 2021 · BMC Psychiatry
Strategies for implementing music‐based interventions for people with dementia in long‐term care facilities: A systematic review
Takashi Amano, Cole Hooley, Joe Strong, Megumi Inoue · 2021 · International Journal of Geriatric Psychiatry
Associations between off-label low-dose olanzapine or quetiapine and cardiometabolic mortality
Jonas Berge, Paul Abri, Pontus Andell, Pouya Movahed, Dragos C. Ragazan · 2021 · Journal of Psychiatric Research
ADN ‐1184 a monoaminergic ligand with 5‐ HT 6/7receptor antagonist activity: pharmacological profile and potential therapeutic utility
Marcin Kołaczkowski, Paweł Mierzejewski, Przemysław Bieńkowski, Anna Wesołowska, Adrian Newman‐Tancredi · 2013 · British Journal of Pharmacology
Off-Label Use of Drugs and Medical Devices: A Review of Policy Implications
Randall Scott Stafford · 2012 · Clinical Pharmacology & Therapeutics
Comodulation of dopamine and serotonin on prefrontal cortical rhythms: a theoretical study
Dahui Wang, KongFatt Wong‐Lin · 2013 · Frontiers in Integrative Neuroscience
Off-label Use of Quetiapine in Medical Inpatients and Postdischarge
Todd Campbell Lee, Ploa Desforges, Jennifer L. Murray, Ramy Saleh, Emily Gibson McDonald · 2016 · JAMA Internal Medicine
Off-Label Prescribing of Psychotropic Medication, 2005–2013: An Examination of Potential Influences
Peggy L. O’Brien, Nicholas Cummings, Tami L. Mark · 2017 · Psychiatric Services
Use of cannabinoid-based medicine among older residential care recipients diagnosed with dementia: study protocol for a double-blind randomised crossover trial
Amanda Timler, Caroline Bulsara, Max Kishor Bulsara, Alistair W. Vickery, Jill Smith, Jim Codde · 2020 · Trials
Prescribing practice and off-label use of psychotropic medications in post-acute brain injury rehabilitation centres: A cross-sectional survey
Federica Edith Pisa, Giorgia Cosano, Manuela Giangreco, Tullio Giorgini, Emanuele Biasutti, Fabio Barbone, Group for the Study of Medication Use in Centers for Post-acute Brain Injury Rehabilitation · 2014 · Brain Injury
Antidiabetic-drug combination treatment for glucose intolerance in adult female rats treated acutely with olanzapine
Heidi N. Boyda, Ric M. Procyshyn, Yahya I. Asiri, Claire Wu, Cathy K. Wang, Ryan Lo, Catherine C.Y. Pang, William G. Honer, Alasdair M. Barr · 2013 · Progress in Neuro-Psychopharmacology and Biological Psychiatry